Following a rigorous inspection by the French National Agency for Medicines and Health Products Safety (ANSM), IRCAD has officially renewed its Good Laboratory Practice (GLP) compliance. Effective December 1st, this certification confirms IRCAD’s adherence to international OECD guidelines for the safety testing of innovative medical devices.
This achievement is the result of two years of cross-functional collaboration and significant investment in cutting-edge laboratory and IT infrastructure. By securing this renewal, IRCAD reinforces its position as a premier global hub for preclinical testing, providing industry partners with the high-standard data required for clinical trials and regulatory submissions.
We extend our congratulations to the multidisciplinary teams whose expertise and dedication made this significant milestone possible.
Please note that the IRCAD administrative board and staff are closely monitoring the evolving COVID-19 situation, in full compliance with all applicable laws and regulations in France. The health, safety, and well-being of our participants, experts and staff are our top priority!
Despite the current context, the IRCAD stands firmly by your side to help you acquire knowledge and skills. Come and join us !
We would like to draw your attention that the « Vaccine Pass » is now mandatory in France since end of January 2022 and replaces the former « Health Pass » to access places that are open to the public, such as cinemas, museums, cafés and restaurants, hotels as well as the IRCAD Institute which welcomes participants in the framework of its courses and seminars. Thus, a PCR test without vaccination is no longer sufficient to take part in our courses.
The vaccine pass includes a proof of the following (one of the 3 items is sufficient):
Further information about the new vaccine pass can be found at :
We very much hope to be able to count on your kind understanding of those rules which have been set by the French Government and which our Institute is required to apply
